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Abstract: In many vitreal diseases, the surgeon removes the natural vitreous and replaces it with
silicone oils, gases, or balanced salt solutions to fill the eyeball and hold the retina in position.
However, these materials are often associated with complications and have properties that differ
from natural vitreous. Herein, we report an extension of our previous work on the synthesis of
a biomimetic hydrogel that is composed of thiolated gellan as an analogue of type II collagen
and poly(methacrylamide-co-methacrylate-co-bis(methacryloyl)cystamine), a polyelectrolyte, as an
analogue of hyaluronic acid. This thermosensitive hydrogel can be injected into the eye as a viscous
solution at 45 ◦ C. It then forms a physical gel in situ when it reaches body temperature, and later
forms disulfide covalent crosslinks. In this article, we evaluated two different formulations of the
biomimetic hydrogels for their physical, mechanical, and optical properties, and we determined
their biocompatibility with several cell lines. Finally, we report on the progress of the four-month
preclinical evaluation of our bio-inspired vitreous substitute in comparison to silicone oil or a balanced
salt solution. We assessed the eyes with a slit-lamp examination, intraocular pressure measurements,
electroretinography, and optical coherence tomography. Preliminary results are very encouraging for
the continuing evaluation of our bio-inspired hydrogel in clinical trials.
Keywords: vitreous; hydrogel; biomimetic; biocompatible; thermoresponsive; sol-gel transition; vitrectomy

1. Introduction
The vitreous is an acellular transparent hydrogel that occupies two-thirds of the total volume of
the eye. Although it is a gelatinous structure, water, both bound and free, constitutes approximately
98–99% of the vitreous, with the remainder being mainly collagen type II fibrils that are interspersed
with hyaluronic acid chains [1]. These two components are primarily responsible for the osmotic
pressure that gives the eye its spherical shape and holds the retina in place [2]. Vitrectomy, which is the
removal of some or all of the natural vitreous, is often used in the treatment of several ophthalmological
pathologies such as retinal detachment and diabetic vitreous hemorrhage. During or after vitrectomy,
a vitreous substitute is needed to reattach or hold the retina in place. Currently used vitreous substitutes
include silicone oil [3,4], saline buffers [5], expansible gases [6], and perfluorocarbons [7]. Each of
these substitutes, however, comes with limitations and is associated with complications, such as
emulsification for silicone oils, expansion of gases at high altitudes, and toxicity of perfluorocarbons.
Materials 2020, 13, 1337; doi:10.3390/ma13061337
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In addition, all of these substitutes noticeably alter the refractive index in the eye [8–10]. Therefore,
there is a need for novel vitreous substitutes that are biocompatible and have similar physical and
optical properties to the natural vitreous.
Polymer-based hydrogels have emerged as promising biomaterials that hold great potential in several
biomedical fields, due to their high water content, optical clarity, and rheological properties [11–13].
Nevertheless, their use as a vitreous substitute has failed because the hydrogels, which are made before
injection, shear-degrade when pushed through the small-gauge needle, changing their mechanical
properties [2,14,15].
Our approach is designed to match the physical and mechanical properties of the natural vitreous
by developing a biocompatible biomimetic vitreous substitute. When injected at 45 ◦ C as a viscous
solution, our substitute almost instantly forms a physical hydrogel in-situ upon cooling to a body
temperature of 37 ◦ C.
Several research groups have investigated the use of in situ forming hydrogels as vitreous
substitutes. Some of the researched materials are hyaluronic acid, polyethylene glycol, and polyvinyl
alcohol [16–21]. The first two polymers are prone to rapid degradation through oxidative damage,
and the last one needs further study to show its long term stability and biocompatibility [22]. For all
three substitutes, however, gelation is not instantaneous, which may result in diffusion of the polymer
solution out of the eye cavity before gelation. Stimuli-responsive materials, on the other hand, can
instantaneously form a three-dimensional structure in response to external stimuli [23]. Examples
of early work in this direction are smart hydrogels made from Pluronic F127 and WTG-127 [24,25].
Despite their desirable physical and mechanical properties, the use of Pluronic F127 resulted in severe
retinal toxicity, while using WTG-127 was associated with low stability and diffusion under the retina
before gelation was complete [22].
Inspired by the natural composition of the vitreous, we here report on the development
of a two-component vitreous substitute that mimics the essential properties of the natural
vitreous. The two-component vitreous substitute is made of gellan, an analogue of collagen,
which undergoes a sol-gel transition at a defined temperature in the presence of cations to
form a physical hydrogel. The mechanism of gelation consists of a random coil-to-double-helix
transition when the temperature is decreased below the transition temperature of gellan [26].
The other component is poly(methacrylamide-co-methacrylate-co-bis(methylacryloyl-cystamine)),
(poly(MAM-co-MAA-co-BMAC), an analogue of hyaluronic acid. This copolymer is an anionic
polyelectrolyte whose role is to control the osmotic pressure and sol-gel transition temperature of
gellan. The monomer BMAC was copolymerized to introduce thiol groups through the copolymer
backbone. Under physiological conditions, thiol groups oxidize and undergo interchain chemical
crosslinking. This step is essential to avoid diffusion of the hydrogel, as previously observed for other
polymers [14]. The other benefit of crosslinking through disulfide bond formation is the possibility of
reversing the oxidation by using a reducing agent, such as glutathione or DTT, and of removing the
vitreous substitute without requiring a second surgery. In this study, we aim to report the progress of
the evaluation of an in-situ-forming two-composite hydrogel in preclinical research and compare its
biocompatibility against silicone oil (positive control) and a buffered salt solution (negative control).
Silicone oils are the current standard of care for large retinal detachment.
2. Experimental Section
2.1. Materials Synthesis and Characterization
We determined the purity of all monomers and the initiator for the free radical polymerization
reaction by quantitative nuclear magnetic resonance (qNMR). An NMR standard certified by the
National Institute of Standards and Technology (NIST) was used. The moisture content of the gellan
was determined by a gravimetric analysis comparing its weight before and after moisture removal.
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1 H NMR spectra were recorded for poly(MAM-co-MAA-co-BMAC) and thiolated gellan by Varian

Unity Inova spectrometer (400 MHz, Agilent Technologies, Santa Clara, CA, USA), using D2 O as a
solvent. A Bruker Avance IIITM HD 600 MHz NMR spectrometer (Billerica, MA, USA) was used to
determine the materials’ purity.
The molecular weight of poly(MAM-co-MAA-co-BMAC) was measured by gel permeation
chromatography (Viscotek GPC system from Malvern PANalytical, Westborough, MA, USA) using a
TDA302 triple detector system (refractive index, multiangle laser light scattering, and viscosity). Samples
were injected at a concentration of 2 mg/mL, and the flow rate was 0.8 mL/min. All measurements were
conducted at 37 ◦ C.
The thiol content in thiolated gellan and poly(MAM-co-MAA-co-BMAC) was measured by
2-nitro-5-thiosulfobenzonate (NTSB) assay, as previously reported [27]. An Abbe refractometer
(ATAGO Abbe Refractometer NAR-1T, Bellevue, WA, USA) was used to determine the refractive index
of the hydrogels at 37 ◦ C and 552 nm.
The transmittance of light between 200 and 800 nm was measured by a Thermo Scientific BioMate
3 UV/Vis spectrophotometer (Waltham, MA, USA). The evaluation of the physical and mechanical
properties of the hydrogels was done as reported earlier [28,29]. We performed all measurements on
hydrogels that were allowed to covalently crosslink for ten days. Briefly, for 3 mL of hydrogels, we
added 1.5 mL of phosphate buffer saline (PBS) buffer 1X and allowed them to swell to equilibrium for
one week. The swollen hydrogels were patted on a tissue paper and dried to remove excess fluid. We
used a gentle vortex to remove any trapped air bubbles. We performed all measurements in triplicate,
at room temperature (23 ◦ C) for transmittance and density, and 37 ◦ C for the refractive index.
For the synthesis of poly(MAM-co-MAA-co-BMAC) and thiolated gellan, a detailed description
is provided elsewhere [28,29]. Two hydrogel formulations were prepared; the first one was made
by mixing 1.5 mg/mL thiolated gellan with 10 mg/mL poly(MAM-co-MAA-co-BMAC), here noted
as 1.5G_10Cop. In the second formulation, we mixed 0.9 mg/mL thiolated gellan with 12 mg/mL
poly(MAM-co-MAA-co-BMAC), here noted as 0.9G_12Cop.
2.2. In Vitro Biocompatibility Testing
In vitro biocompatibility testing was achieved by using electrical cell-substrate impedance sensing
ECIS (Applied BioPhysics, Troy, NY, USA) as previously reported [29]. Thiolated gellan was dissolved
in sterile N2 -bubbled water, the poly(MAM-co-MAA-co-BMAC) was dissolved in sterile 2X Dulbecco’s
Modified Eagles’ Medium/Nutrient Mixture F-12 Ham (DMEM/F12) media, and the pH was adjusted
to 7.4 with 1M NaOH. The thiolated gellan and poly(MAM-co-MAA-co-BMAC) solutions were then
heated separately at 45 ◦ C for 15 min in a water bath and mixed immediately before exposure to the cells.
The hydrogel solution was cast over the cells to ensure direct contact. In vitro biocompatibility testing
was monitored using electrical cell-substrate impedance sensing (ECIS from Applied BioPhysics, Troy,
NY, USA). The ECIS is a non-invasive technique that measures the impedance across gold electrodes
at the bottom of tissue culture wells, using a range of frequencies of alternating current. After the
initial seeding, the cells start to grow over the gold electrodes and increase the resistance to current
flow; therefore, the impedance across the electrodes increases. In response to stimuli (in this case,
the hydrogels), the degree to which cells are attached to the electrodes may change. This change is
reflected in the impedance recordings in real-time. The improved biocompatibility is interpreted as an
increase in impedance compared to the control cells, which are not exposed to any vitreous substitutes.
Two sets of experiments were performed in this work. The first aimed to determine the
biocompatibility of the hydrogels on a confluent layer of cells. Confluence was obtained by plating the
primary porcine retinal epithelial cells (ppRPE) at a high cell density of 40,000 cells/well; human retinal
pigment epithelial (ARPE-19) cells at 20,000 cells/well, and 3T3/NIH (fibroblasts) cells at 10,000 cells/well
in an ECIS cultureware, 96-well plate. Upon confirmation of confluency, the polymer solution was
added. In the second set of experiments, the cells were plated at low density (ppRPE at 10,000 cells/well,
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ARPE-19 at 5000 cells/well, and 3T3/NIH at 4000 cells/well), and the polymer solution was added the
following day to investigate the proliferation of cells in the presence of the gel.
The CellTiter–Glo assay (Promega, Madison, WA, USA), which determines the number of viable
cells based on ATP quantitation, was done according to the manufacturer’s instructions. The toxicity
of the hydrogel formulations was tested on 3T3/NIH and primary porcine retinal epithelial (ppRPE)
cells at two different cell seeding concentrations: proliferating (low cell density) and confluent
(high cell density). For the biocompatibility experiments, the low and cell density numbers were
used as determined in our previous studies [29–31]. The ppRPE cells were plated at a cell density
of 40,000 cells/well, and the 3T3/NIH (fibroblasts) cells at 10,000 cells/well for the high cell density
experiments. On the other hand, for the low cell density experiments, the cells were plated at
4000 cells/well and 10,000 cells/well for 3T3/NIH cells and ppRPE cells, respectively.
The ARPE-19 and 3T3/NIH cell lines were purchased from American Type Culture Collection
(Manassas, VA, USA). The ppRPE cells were cultured and seeded, as previously described [29,31].
2.3. Animal Studies
All animal studies were approved and guided by the Washington University School of Medicine
(WU) and the United States Department of Defense (US DoD, protocol number 20180105, approval date
05/23/2018). Over several months, we completed 11 two-port partial pars plana vitrectomy surgeries on
Dutch belted rabbits. Among these, five of the rabbits have reached the four-month observation time
point. One rabbit received the silicone-oil vitreous replacement, two rabbits received a buffered salt
solution (BSS) replacement, and two received the hydrogel substitute form the 1.5G_10CoP formulation.
The ocular status of the rabbit eyes were examined by electroretinography (ERG, RETevet,
Gaithersburg, MD, USA), optical coherence tomography (OCT, Standard-Resolution 800 nm OCT
System, Wasatch Photonics, Morrisville, NC, USA), slit-lamp examinations (PSL Classic Portable Slit
Lamp, Keeler, Malvern, PA, USA) and intraocular eye pressure (IOP) measurements (Tono-Pen AVIA
Tonometer, Reichert Technologies, Depew, NY, USA). These evaluations were performed before the
start of surgery, at the one-month mark, and the four-month endpoint.
The surgeries were performed under general anesthesia, and vitals were monitored by the
Department of Comparative Medicine (DCM) veterinarian staff. The surgical procedure was as follows:
the rabbits were prepped and draped in a sterile surgical environment. The right eye (surgical eye) of
each rabbit received a randomly chosen substitute to be placed in the eye.
Two 23-gauge trocars were inserted into the vitreous cavity from the temporal side, 2 mm from
the limbus; one trocar was used for infusion of balanced salt solution (BSS), and the other to access the
vitreous cavity. A 23-gauge vitrector probe (Millennium, Bausch & Lomb, San Dimas, CA, USA) was
inserted into the rabbit’s temporal vitreous chamber, and 0.3–0.4 mL of the vitreous gel was partially
removed, a fluid−air exchange was performed, and 0.3–0.4 mL of 1.5G_10Cop, silicone oil or balanced
salt solution (BSS) was injected to replace the natural vitreous (Figure 1).
The left eye remained untreated as the control. Identical procedures were performed on rabbits
who received silicone-oil and BSS. The rabbits received sub-conjunctival injections of gentamicin
and dexamethasone to prevent post-operative infection and inflammation at the end of the surgical
procedure. The IOP was measured immediately following the surgery. The IOP post-surgery ranged
from 14–25 mmHg but was within normal limits the next day.
The surgical eyes were checked once or twice daily for up to one week. Depending on the eye’s
condition upon slit-lamp examination, post-surgical treatments consisted of neomycin, polymyxin
B sulfates, dexamethasone ophthalmic ointment (anti-fungal), gentamicin 0.3% ophthalmic solution
(antibiotic), and atropine 1% ophthalmic solution (pupil dilation). The average recovery time following
the surgery was one week.
ERGs were performed to measure the electrical activity generated by cells in the retina and
to monitor the functioning of the retina with a three-step scotopic and two-step photopic protocol
with flicker and flash testing. Additional information on the ERG analysis can be found in the
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Figure 1. Image of a rabbit’s eye. Yellow region indicates the area where the natural vitreous was
removed during the two-port partial pars plana vitrectomy.

3. Results and Discussion
3.1. Synthesis and Properties of the Thermoresponsive Hydrogels
Thiolated gellan and poly(MAM-co-MAA-co-BMAC) (78% methacrylamide:20% methacrylic
acid:2% bis-methacryloylcystamine) were synthesized according to our previously reported
methods [28,29]. Using the NTSB essay [27] and 1 H NMR analysis, we determined that thiolated
gellan and poly(MAM-co-MAA-co-BMAC) have thiol contents of 11% (mol) and 2% (mol), respectively.
The thiol content can be fine-tuned; however, we previously determined that increasing the thiol
content negatively affects the biocompatibility of the hydrogel [28]. To determine the incorporation
ratio of methacrylic acid, a solution of poly(MAM-co-MAA-co-BMAC) was titrated with a standard
solution of 1 N NaOH. The incorporation ratio of methacrylic acid was found to be 19.31% ± 0.54, which
is very close to the feed ratio of the monomer (20%). We measured the number average molecular
weight of poly(MAM-co-MAA-co-BMAC) by gel permeation chromatography (GPC). Five batches
of poly(MAM-co-MAA-co-BMAC) were synthesized, from which three were combined due to their
similar molecular weights (311,256 g/mol ± 28,223).
In this study, two hydrogel formulations were synthesized by combining thiolated gellan and
poly(MAM-co-MAA-co-BMAC) in different concentrations. In both formulations, the components
were separately heated, then mixed at 55 ◦ C. The sol-gel transition temperature was determined by a
temperature scan from 55 to 15 ◦ C, at a controlled cooling rate of 2 ◦ C/min, following the loss modulus
at 5% constant shear strain and 1.0 Hz constant frequency, using an Anton Paar rheometer MCR 302.
As noted above, a good vitreous substitute should form a hydrogel in situ to avoid shear degradation
when it is injected through a small gauge needle. However, failure to form a gel instantaneously may
result in the polymers diffusing away from the injection site through retinal breaks [8]. Our hydrogels,
however, are thermoresponsive; they can be injected at 45 ◦ C as a viscous solution and form hydrogels
almost immediately after they cool to body temperature. The sol-gel transition temperature of thiolated
gellan at the studied concentrations falls in the range of 34–36 ◦ C. The sol-gel transition temperatures
of 1.5G_10Cop and 0.9G_12Cop are observed to be ~42 ◦ C (Figure S12).
In addition to its effects in tuning the sol-gel transition temperature of thiolated gellan,
poly(MAM-co-MAA-co-BMAC) also causes the hydrogels to swell and exert pressure, which is
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essential in holding the retina in place. The mixed thiolated gellan and poly(MAM-co-MAA-co-BMAC)
were cast into 35-mL pre-weighed dishes, and the solutions were left to chemically crosslink via thiol
oxidation at 37 ◦ C for ten days in a humidified chamber. After chemical crosslinking, PBS (in the
absence of Ca2+ and Mg2+ ) was added on top of the hydrogels. The swelling equilibrium was reached
when no change in hydrogel’s weight was observed. The swelling percentages for each formulation
were determined to be 17.74 ± 1.08% for 1.5G_10Cop, and 26.62 ± 2.06 for 0.9G_12Cop. A higher
concentration of poly(MAM-co-MAA-co-BMAC) results in more swelling due to its ionic character and
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Figure
measurements with
withthe
thetwo
twohydrogel
hydrogelformulations
formulations
confluent
APRE-19,
Figure3.3. Resistance
Resistance measurements
ofof
confluent
(A)(A)
APRE-19,
(B)
(B)
ppRPE,
3T3
cells;and
andproliferating
proliferating(D)
(D)ARPE-19,
ARPE-19,(E)
(E) ppRPE,
ppRPE, and
and (F)
ppRPE,
(C)(C)
3T3
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(F) 3T3/NIH
3T3/NIH cells.
cells. Values
Valuesare
are
given
givenininmean
mean±±SEM
SEM(n
(n== 4).
4).

Compared to untreated cells, we observed that cell growth might be stimulated slightly upon
the first addition of both materials.
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biocompatibility analysis, we evaluated the statistical significance using analysis of variance
(ANOVA)
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(Figure
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72
h.
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results
indicated
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two
formulations
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(Figure
biocompatibility analysis, we evaluated the statistical significance using analysis of variance (ANOVA)
4A). On the
theresults
other with
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two formulations
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of significance
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to compare
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negative (untreated
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and group.
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Figure 4. The viability of confluent (A) ppRPE, and (B) 3T3/NIH cells after exposure to thiolated
Figure
4. The viability of confluent (A)
and (B)components
3T3/NIH cells
thiolated
gellan,
poly(MAM-co-MAA-co-BMAC),
andppRPE,
the combined
for after
72 h. exposure
Values aretogiven
in
gellan,
poly(MAM-co-MAA-co-BMAC),
and the combined components for 72 h. Values are given in
mean
± SEM
(n = 6).
mean ± SEM (n = 6).

For the biocompatibility experiments, ppRPE and 3T3/NIH (fibroblasts) cells were exposed to
Overall, our results
indicate
that both
vitreous
substitute formulations
made from
thiolated
three concentrations
of gellan
(0.9-1.5-2.0
mg/mL)
and copolymers
(10-12-15 mg/mL),
respectively.
gellan
and
poly(MAM-co-MAA-co-BMAC),
in
addition
to
their
individual
components,
Finally, we tested the biocompatibility of the two formulations of our hydrogels on both cell types forare
with confluent
and
pRPE, and
3T3/NIH
cells.
72 biocompatible
h. The results indicated
that the
twoproliferating
formulationsARPE-19,
were compatible
with
the ppRPE
cells (Figure 4A).
On the other hand, these two formulations slightly decreased the viability of the 3T3/NIH (fibroblasts)
3.3.(Figure
Animal4B).
Studies
cells
Overall,
our results
that
both vitreous
substitute
formulations
from thiolated
gellaneye
Pre-surgical
ERGsindicate
showed
overlapping
latencies
(time-to-peak)
andmade
amplitudes
for the right
and
poly(MAM-co-MAA-co-BMAC),
in addition
to their
are biocompatible
and
the left eye, indicating similar results
for both
eyesindividual
at the timecomponents,
of testing. Photopic
b-wave and
with
confluent
and
proliferating
ARPE-19,
pRPE,
and
3T3/NIH
cells.
flicker amplitudes were similar for both eyes. The differences in summed oscillatory potential

amplitudes may reflect electrical “noise” in some recordings.
3.3. Animal Studies
As seen in Figure 5, one-month post-operative ERGs show that, although there is some
individual
variation,
in b-wave latency
and(time-to-peak)
amplitude, results
the control
eyes
show
Pre-surgical
ERGs especially
showed overlapping
latencies
and from
amplitudes
for the
right
eyenoand
the left eye,
indicating
results eyes.
for both
eyes at theare
time
of testing. higher
Photopic
b-wave
significant
difference
fromsimilar
the surgical
Amplitudes
substantially
than
in preand
flickertests,
amplitudes
were
similar
for both
eyes.
The differences
in summed
oscillatory
potential
surgical
indicating
vision
is likely
being
redefined
or developed
in the rabbits
during
the time
between tests.
amplitudes
may reflect electrical “noise” in some recordings.
As seen in Figure 5, one-month post-operative ERGs show that, although there is some individual
variation, especially in b-wave latency and amplitude, results from the control eyes show no significant
difference from the surgical eyes. Amplitudes are substantially higher than in pre-surgical tests,
indicating vision is likely being redefined or developed in the rabbits during the time between tests.
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The five rabbits that reached the four-month marker were euthanized, and their eyes have been
enucleated for histology analysis. Currently, we have obtained hematoxylin and eosin (H&E) staining
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formulate a conclusion for the retinal morphology changes. However, we do not see significant
differences thus far.
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Figure 7. H&E staining on polyelectrolyte #1, silicone-oil, and control (BSS). The retina is detached
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Figure 8. IOP changes graphed over time following the two-port partial pars plana vitrectomy. Red
data points = control eyes; blue data points = surgical eyes. The red marker at 0 on the x-axis indicates
the time immediately following the vitrectomy.
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The
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of twothe time immediately following the vitrectomy.
component
vitreous substitutes at two different concentrations. The vitreous substitutes were
4.
Conclusions
4.
Conclusions
designed
by reverse-engineering the features of the natural vitreous. In both formulations, the
The substitute
present work
reports
the synthesis,behavior
properties,
and progress
preclinical
tests of
vitreous
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The present work reports the synthesis, properties, and progress of preclinical tests of twotwo-component
vitreous
substitutes
at
two
different
concentrations.
The
vitreous
substitutes
were
solution that then gels when it cools to body temperature. Following the initial, almost instantaneous
component vitreous substitutes at two different concentrations. The vitreous substitutes were
designed
by reverse-engineering
the features
of the natural
vitreous.reversible
In both formulations,
the vitreous
gelling via
physical crosslinking,
the hydrogels
start forming
chemical crosslinking
designed by reverse-engineering the features of the natural vitreous. In both formulations, the
vitreous substitute exhibits thermoresponsive behavior that enables it to be injected as a viscous
solution that then gels when it cools to body temperature. Following the initial, almost instantaneous
gelling via physical crosslinking, the hydrogels start forming reversible chemical crosslinking
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substitute exhibits thermoresponsive behavior that enables it to be injected as a viscous solution that
then gels when it cools to body temperature. Following the initial, almost instantaneous gelling
via physical crosslinking, the hydrogels start forming reversible chemical crosslinking through the
oxidation of thiol to disulfide groups. Both formulations closely mimic natural vitreous. Toxicity
studies on our vitreous substitutes reveal that they are biocompatible with several confluent and
proliferating cell lines.
Preclinical studies on the four-month post-operative outcome of the two-port partial pars plana
vitrectomy surgeries show no apparent signs or symptoms of inflammation in the anterior segment of
the rabbits’ eyes. The rabbits’ corneas were transparent, and the anterior chambers were deep and quiet.
There were partial opacities at the surgical site of the lens when viewed with the portable slit-lamp;
otherwise, the lens was clear. Additionally, none of the rabbits in the four-month post-operative
period developed a cataract. Further evaluation of the synthesized hydrogels as a vitreous substitute
is ongoing, though current results suggest that it is a promising superior alternative to currently
used materials.
Supplementary Materials: The following are available online at http://www.mdpi.com/1996-1944/13/6/1337/s1.
Figure S1. Reaction scheme of BMAC synthesis, Figure S2. 1 H NMR spectra of the synthesized & purified
BMAC, Figure S3. FTIR spectrum of the synthesized and purified BMAC, Figure S4. 1 H NMR spectrum of
AIBN and benzoic acid standard, Figure S5. 1 H NMR spectrum of BMAC and benzoic acid standard, Figure S6.
1 H NMR spectrum of MAM and benzoic acid standard, Figure S7. 1 H NMR spectrum of MAA, before distillation,
and benzoic acid standard, Figure S8. 1 H NMR spectrum of MAA, after distillation, and benzoic acid standard,
Figure S9. Reaction scheme of the copolymerization of MAM, MAA, and BMAC, Figure S10: 1 H NMR of
Poly(MAM-co-MAA-co-BMAC), Figure S11. Reaction scheme of gellan amidation, Figure S12: Temperature scan
of thiolated gellan and thiolated gellan-copolymer, formulation 1.5G_10CoP, and 0.9G_12CoP, to determine the
random coil-to-double-helix phase transition of thiolated Gellan (taken as the middle point of the loss modulus
increase). The midpoint of the curves in both mixtures is ~42 ◦ C. Finally, additional information on the ERG
analysis is available.
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